Virulence factors as predictive tools for drug resistance in pseudomonas aeruginosa

Virulence

Volumn 6, Issue 7, 2015, Pages 679-683

  Pereira, Sonia Gonçalves ^a   Rosa, Ana Cristina ^b   Cardoso, Olga ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; MEROPENEM; PHOSPHOLIPASE C; PIPERACILLIN; PYOCYANINE; PYOVERDINE; RHAMNOLIPID; VIRULENCE FACTOR; ANTINEOPLASTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; DNA HYBRIDIZATION; EXOT GENE; EXOY GENE; FALSE NEGATIVE RESULT; GENETIC ASSOCIATION; HUMAN; LECA GENE; LECB GENE; LETTER; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPIC VARIATION; PHOSC GENE; PHZH GENE; PHZM GENE; POLYMERASE CHAIN REACTION; PREVALENCE; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RHAMN GENE; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; GENOTYPE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; PHENOTYPE; PSEUDOMONAS INFECTION; VIRULENCE;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VIRULENCE; VIRULENCE FACTORS;

EID: 84983666613     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.1080/21505594.2015.1048958     Document Type: Letter

References (22)

1. Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromossomally encoded resistance mechanisms. Clin Microbiol Rev 2009; 22: 582-610; PMID:19822890; http://dx.doi.org/10.1128/CMR.00040-09
2. Fricks-Lima J, Hendrickson CM, Allgaier A, Zhuo H, Wiener-Kronish JP, Lynch SV, Yang K. Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients. Int J Antimicrob Agents 2011; 37: 309-15; PMID:21382698; http://dx.doi.org/10.1016/j.ijantimicag.2010.12.017
3. Pereira SG, Rosa AC, Ferreira AS, Moreira LM, Proença DN, Morais PV, Cardoso O. Virulence factors and infection ability of Pseudomonas aeruginosa isolates from a hydropathic facility and respiratory infections. J Appl Microbiol 2014; 116: 1359-68; PMID:24484457; http://dx.doi.org/10.1111/jam.12463
4. Finlayson EA, Brown PD. Comparison of antibiotic resistance and virulence factors in pigmented and nonpigmented Pseudomonas aeruginosa. West Indian Med J 2011; 60: 24-32; PMID:21809707
5. Jeannot K, Elsen S, Kohler T, Attree I, Van Delden C, Plesiat P. Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump. Antimicrob Agents Chemother 2008; 52: 2455-62; PMID:18474583; http://dx.doi.org/10.1128/AAC.01107-07
6. Ramisse F, Van Delden C, Gidenne S, Cavallo J, Hernandez E. Decreased virulence of a strain of Pseudomonas aeruginosa O12 overexpressing a chromosomal type 1 b-lactamase could be due to reduced expression of cell-to-cell signaling dependent virulence factors. FEMS Immunol Med Microbiol 2000; 28: 241-5; PMID:10865177
7. Cathcart GRA, Quinn D, Greer B, Harriot P, Lynas JF, Gilmore BF, Walker B. Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection. Antimicrob Agents Chemother 2011; 55: 2670-8; PMID:21444693; http://dx.doi.org/10.1128/AAC.00776-10
8. Chemani C, Imberty A, de Bentzmann S, Pierre M, Wimmerova M, Guery BP, Faure K. Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infect Immun 2009; 77: 2065-75; PMID:19237519; http://dx.doi.org/10.1128/IAI.01204-08
9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. M100-S19. Wayne, PA, 2009
10. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2011; 18: 268-81; PMID:21793988; http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x
11. Inoue T, Shingaki R, Fukui K. Inhibition of swarming motility of Pseudomonas aeruginosa by branched-chain fatty acids. FEMS Microbiol Lett 2008; 281: 81-6; PMID:18318842; http://dx.doi.org/10.1111/j.1574-6968.2008.01089.x
12. Smibert RM, Krieg NR. General characterization. Washington DC: American Society for Microbiology, c1981, p. 409-433 Gerhardt P, Murray RGE, Costilow RNE, Nester W, Wood WA, Krieg NR, Phillips GH, editors. Manual methods for general microbiology
13. Finnan S, Morrissey JP, O’Gara F, Boyd EF. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol 2004; 42: 5783-92; PMID:15583313; http://dx.doi.org/10.1128/JCM.42.12.5783-5792.2004
14. Janda JM, Bottone EJ. Pseudomonas aeruginosa enzyme profiling: predictor of potential invasiveness and use as an epidemiological tool. J Clin Microbiol 1981; 14: 55-60; PMID:6790569
15. Mavrodi DV, Bonsall RF, Delaney SM, Soule MJ, Phillips G, Thomashow LS. Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from Pseudomonas aeruginosa PAO1. J Bacteriol 2001; 183: 6454-65; PMID:11591691; http://dx.doi.org/10.1128/JB.183.21.6454-6465.2001
16. Berka RM, Gray GL, Vasil ML. Studies of phospholipase C (heat-label hemolysin) in Pseudomonas aeruginosa. Infect Immun 1981; 34: 1071-4; PMID:6800952
17. Choy MH, Stapleton F, Willcox MDP, Zhu H. Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-and non-contact lens-related keratitis. J Med Microbiol 2008; 57: 1539-46; PMID:19018027; http://dx.doi.org/10.1099/jmm.0.2008/003723-0
18. McMorran BJ, Kumara HMCS, Sullivan K, Lamont IL. Involvement of a transformylase enzyme in siderophore synthesis in Pseudomonas aeruginosa. Microbiology 2001; 147: 1517-24; PMID:11390682
19. Kaszab E, Kriszt B, Atzel B, Szabo G, Szabo I, Harkai P, Szoboszlay S. The occurrence of multidrug-resistant Pseudomonas aeruginosa on hydrocarbon-contaminated sites. Microb Ecol 2010; 59: 37-45; PMID:19597862; http://dx.doi.org/10.1007/s00248-009-9551-7
20. Field A, Logistic regression. London: Sage Publications Ltd, c2005, p. 760-813 Field A, editor. Discovering Statistics Using SPSS Statistics, 2th edition
21. Lamont IL, Konings AF, Reid DW. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Biometals 2009; 22: 53-60; PMID:19130260; http://dx.doi.org/10.1007/s10534-008-9197-9
22. Balasubramanian D, Schneper L, Kumari H, Mathee K. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res 2012; 41: 1-20; PMID:23143271; http://dx.doi.org/10.1093/nar/gks1039